Clinical trial
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's…
NCT00434304 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00434304 |
|---|---|
| Title | Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) |
| Official title | Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study - |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Ropinirole prolonged release/extended release(PR/XR) |
| Enrollment | 62 |
| Start date | Apr 9, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 10, 2009 |
| First posted | Feb 13, 2007 |
| Last update posted | Sep 27, 2018 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: